Shanghai Yizhong Pharmaceutical Co Ltd Capital Reinvestment Ratio
Shanghai Yizhong Pharmaceutical Co Ltd capital reinvestment ratio. Shanghai Yizhong Pharmaceutical Co Ltd (688091) has a Capital Reinvestment Ratio of 1.44x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥21.03 Million) in capital expenditures (CN¥30.36 Million). See Shanghai Yizhong Pharmaceutical Co Ltd (688091) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Shanghai Yizhong Pharmaceutical Co Ltd (2022–2024)
Capital reinvestment ratio of Shanghai Yizhong Pharmaceutical Co Ltd from 2022 to 2024. This chart tracks Shanghai Yizhong Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 3 annual periods. See 688091 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Shanghai Yizhong Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2022–2024)
Shanghai Yizhong Pharmaceutical Co Ltd capital reinvestment ratio by year from 2022 to 2024. For the full cash flow conversion analysis, see Shanghai Yizhong Pharmaceutical Co Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.03x | CN¥39.44 Million | CN¥80.04 Million | ▲ +1900.3% |
| 2023 | 0.10x | CN¥86.55 Million | CN¥8.78 Million | ▼ -68.7% |
| 2022 | 0.32x | CN¥110.78 Million | CN¥35.88 Million | — |